AbbVie Inc.
ABBV
$195.22
$6.203.28%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.20B | 4.28B | 5.12B | 5.34B | 5.99B |
| Total Depreciation and Amortization | 8.35B | 8.39B | 8.36B | 8.52B | 8.65B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.46B | 8.92B | 4.97B | 4.85B | 4.18B |
| Change in Net Operating Assets | -5.61B | -2.78B | -1.94B | -65.00M | 3.87B |
| Cash from Operations | 16.40B | 18.81B | 16.51B | 18.64B | 22.69B |
| Capital Expenditure | -1.02B | -974.00M | -888.00M | -858.00M | -795.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -11.67B | -20.52B | -19.28B | -10.94B | -10.26B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 715.00M | 671.00M | 420.00M | -59.00M | -44.00M |
| Cash from Investing | -11.97B | -20.82B | -19.75B | -11.86B | -11.10B |
| Total Debt Issued | 7.59B | 21.97B | 19.97B | 19.97B | 19.97B |
| Total Debt Repaid | -12.54B | -14.62B | -10.65B | -10.25B | -7.91B |
| Issuance of Common Stock | 143.00M | 214.00M | 235.00M | 204.00M | 242.00M |
| Repurchase of Common Stock | -1.35B | -1.71B | -1.35B | -1.34B | -1.34B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.18B | -11.03B | -10.90B | -10.78B | -10.65B |
| Other Financing Activities | 44.00M | -42.00M | -100.00M | -196.00M | -527.00M |
| Cash from Financing | -17.29B | -5.21B | -2.80B | -2.39B | -211.00M |
| Foreign Exchange rate Adjustments | -38.00M | -65.00M | 4.00M | -20.00M | -21.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.89B | -7.29B | -6.03B | 4.37B | 11.36B |